Supaglutide
The Progress of Diabetes After Supaglutide Treatment in Type 2 Diabetes Patients
Shanghai Yinnuo Pharmaceutical Technology Co. · Phase n/r · Status n/r · Enrollment 100
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Supaglutide Treatment | n/r | n/r | n/r | n/r |
Not shown
- Supaglutide Treatment: endpoint not reported